Skip to content
10-Q

Quarterly Report

Carisma Therapeutics Inc.

0001104659-25-110444

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 41.85M sh
Shares Diluted Q3 2025 · Sep 30, 2025 41.94M sh
Shares Diluted Q3 2025 · Sep 30, 2025 41.94M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 41.59M sh
Shares Diluted Q3 2025 · Sep 30, 2024 41.36M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $123K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$14.06M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$51.57M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $2.78M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $17.91M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.81M
Current Liabilities Q3 2025 · Dec 31, 2024 $16.06M
Total Liabilities Q3 2025 · Sep 30, 2025 $7.42M
Total Liabilities Q3 2025 · Dec 31, 2024 $58.37M
Current Assets Q3 2025 · Sep 30, 2025 $5.87M
Current Assets Q3 2025 · Dec 31, 2024 $23.83M
Total Assets Q3 2025 · Sep 30, 2025 $6.55M
Total Assets Q3 2025 · Dec 31, 2024 $30.46M
Eps Diluted Q3 2025 · Sep 30, 2025 $1.07
Eps Diluted Q3 2025 · Sep 30, 2025 $0.61
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.31
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.04
Eps Basic Q3 2025 · Sep 30, 2025 $1.07
Eps Basic Q3 2025 · Sep 30, 2025 $0.61
Eps Basic Q3 2025 · Sep 30, 2024 −$0.31
Eps Basic Q3 2025 · Sep 30, 2024 −$1.04
Sga Expense Q3 2025 · Sep 30, 2025 $1.24M
Sga Expense Q3 2025 · Sep 30, 2025 $8.5M
Sga Expense Q3 2025 · Sep 30, 2024 $5.2M
Sga Expense Q3 2025 · Sep 30, 2024 $16.21M
Rd Expense Q3 2025 · Sep 30, 2025 $197K
Rd Expense Q3 2025 · Sep 30, 2025 $11.78M
Rd Expense Q3 2025 · Sep 30, 2024 $11.33M
Rd Expense Q3 2025 · Sep 30, 2024 $44.1M
Net Income Q3 2025 · Sep 30, 2025 $44.72M
Net Income Q3 2025 · Sep 30, 2025 $25.68M
Net Income Q3 2025 · Jun 30, 2025 −$9.77M
Net Income Q3 2025 · Mar 31, 2025 −$9.27M
Net Income Q3 2025 · Sep 30, 2024 −$12.7M
Net Income Q3 2025 · Sep 30, 2024 −$42.84M
Net Income Q3 2025 · Jun 30, 2024 −$11.16M
Net Income Q3 2025 · Mar 31, 2024 −$18.98M
Operating Income Q3 2025 · Sep 30, 2025 $43.81M
Operating Income Q3 2025 · Sep 30, 2025 $28.7M
Operating Income Q3 2025 · Sep 30, 2024 −$13.14M
Operating Income Q3 2025 · Sep 30, 2024 −$44.32M
Revenue Q3 2025 · Sep 30, 2025 $45.3M
Revenue Q3 2025 · Sep 30, 2025 $49M
Revenue Q3 2025 · Sep 30, 2024 $3.4M
Revenue Q3 2025 · Sep 30, 2024 $16M